Noninvasive Monitoring of Mantle Cell Lymphoma by Immunoglobulin Gene Next-Generation Sequencing in a Phase 2 Study of Sequential Chemoradioimmunotherapy Followed by Autologous Stem-Cell Rescue

Limited information exists in mantle cell lymphoma (MCL) on the performance of next-generation sequencing–based assay of immunoglobulin gene rearrangements for minimal residual disease (MRD) assessment. Posttreatment peripheral blood samples were collected from 16 MCL patients and analyzed with the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Anita, Bantilan, K.S., Jacob, A.P., Park, A., Schoninger, S.F., Sauter, C., Ulaner, G.A., Casulo, C., Faham, M., Kong, K.A., Grewal, R.K., Gerecitano, J., Hamilton, A., Hamlin, P., Matasar, M., Moskowitz, C.H., Noy, A., Palomba, M.L., Portlock, C.S., Younes, A., Willis, T, Zelenetz, A.D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476895/
https://www.ncbi.nlm.nih.gov/pubmed/33558202
http://dx.doi.org/10.1016/j.clml.2020.09.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476895/
https://www.ncbi.nlm.nih.gov/pubmed/33558202
http://dx.doi.org/10.1016/j.clml.2020.09.007

Ejemplares similares